BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9279107)

  • 1. [Stomach cancer].
    Yasui W; Tahara E
    Tanpakushitsu Kakusan Koso; 1997 Jul; 42(10 Suppl):1739-46. PubMed ID: 9279107
    [No Abstract]   [Full Text] [Related]  

  • 2. [Molecular mechanisms of carcinogenesis and progression of human stomach cancer].
    Yokozaki H; Tahara E
    Nihon Rinsho; 2001 Apr; 59 Suppl 4():31-8. PubMed ID: 11424398
    [No Abstract]   [Full Text] [Related]  

  • 3. Gene alterations in intestinal metaplasia and gastric cancer.
    Tahara E; Kuniyasu H; Yasui W; Yokozaki H
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S97-102. PubMed ID: 7735945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lung cancer].
    Osada H; Takahashi T
    Tanpakushitsu Kakusan Koso; 1997 Jul; 42(10 Suppl):1732-8. PubMed ID: 9279106
    [No Abstract]   [Full Text] [Related]  

  • 5. [Gynecologic malignancies].
    Sagae S; Koizumi M; Terasawa K; Kobayashi K; Kudo R
    Tanpakushitsu Kakusan Koso; 1997 Jul; 42(10 Suppl):1762-70. PubMed ID: 9279110
    [No Abstract]   [Full Text] [Related]  

  • 6. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
    Engelhardt M; Albanell J; Drullinsky P; Han W; Guillem J; Scher HI; Reuter V; Moore MA
    Clin Cancer Res; 1997 Oct; 3(10):1849-57. PubMed ID: 9815573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Trends in molecular genetic research on human stomach cancer].
    Fedorov SN; Levanova GI; Guliaev AV; Kalinovskiĭ VP; Khanson KP
    Vopr Onkol; 1993; 39(4-6):149-52. PubMed ID: 7975388
    [No Abstract]   [Full Text] [Related]  

  • 8. [Contribution of molecular biology to the evaluation of prognosis in cancer of the stomach].
    Velu T
    Pathol Biol (Paris); 1993 Jan; 41(1):76-7. PubMed ID: 8316480
    [No Abstract]   [Full Text] [Related]  

  • 9. Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer.
    Yu J; Cheng YY; Tao Q; Cheung KF; Lam CN; Geng H; Tian LW; Wong YP; Tong JH; Ying JM; Jin H; To KF; Chan FK; Sung JJ
    Gastroenterology; 2009 Feb; 136(2):640-51.e1. PubMed ID: 19084528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and epigenetic alterations in multistep carcinogenesis of the stomach.
    Yasui W; Yokozaki H; Fujimoto J; Naka K; Kuniyasu H; Tahara E
    J Gastroenterol; 2000; 35 Suppl 12():111-5. PubMed ID: 10779229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic pathways of two types of gastric cancer.
    Tahara E
    IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic alterations in gastric cancer with special reference to the histological type].
    Yokozaki H; Yasui W; Kuniyasu H; Tahara E
    Rinsho Byori; 1993 Jun; Suppl 94():19-28. PubMed ID: 8361007
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic alterations in human prostate cancer: a review of current literature.
    Ozen M; Pathak S
    Anticancer Res; 2000; 20(3B):1905-12. PubMed ID: 10928125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomerase activity as prognostic factor in gastrointestinal stromal tumors of the stomach.
    Kawai J; Kodera Y; Fujiwara M; Kasai Y; Nagasaka T; Koike M; Hibi K; Ito K; Akiyama S; Nakao A
    Hepatogastroenterology; 2005; 52(63):959-64. PubMed ID: 15966241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The significance of telomerase activity in patients with gastric cancer].
    Yagihashi A; Kameshima H; Yajima T; Watanabe N; Denno R; Hirata K
    Rinsho Byori; 1998 Jan; 46(1):5-8. PubMed ID: 9492531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of the potential suppressor gene IGFBP-rP1 in human breast cancer is associated with inactivation of the retinoblastoma protein, cyclin E overexpression and increased proliferation in estrogen receptor negative tumors.
    Landberg G; Ostlund H; Nielsen NH; Roos G; Emdin S; Burger AM; Seth A
    Oncogene; 2001 Jun; 20(27):3497-505. PubMed ID: 11429696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase activity could be used as a marker for neoplastic transformation in gastric adenocarcinoma: but it does not have a prognostic significance.
    Gümüş-Akay G; Unal AE; Bayar S; Karadayi K; Elhan AH; Sunguroĝlu A; Tükün A
    Genet Mol Res; 2007 Feb; 6(1):41-9. PubMed ID: 17469053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Necessity of chip technology in stomach cancer].
    Galamb O; Sipos F; Molnár B; Tulassay Z
    Orv Hetil; 2004 May; 145(18):939-47. PubMed ID: 15188640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cancer genetics. A review of oncological molecular biology seen in relation to the human genome].
    Gerdes AM
    Ugeskr Laeger; 2002 May; 164(22):2865-71. PubMed ID: 12082811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characteristics of eight gastric cancer cell lines established in Japan.
    Yokozaki H
    Pathol Int; 2000 Oct; 50(10):767-77. PubMed ID: 11107048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.